Have a feature idea you'd love to see implemented? Let us know!

ACTU Actuate Therapeutics Inc.

  1. Stocks
  2. Healthcare
  3. NASDAQ: ACTU

Price (delayed)

$7.69

Market cap

$150.2M

P/E Ratio

N/A

Dividend/share

N/A

EPS

N/A

Enterprise value

$136.67M

We are a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). We ...

Highlights
Actuate Therapeutics's equity has soared by 105% from the previous quarter
ACTU's debt has shrunk by 100% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: https://actuatetherapeutics.com
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of ACTU
Market
Shares outstanding
19.53M
Market cap
$150.2M
Enterprise value
$136.67M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
28.03
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
N/A
Gross profit
N/A
Operating income
N/A
Net income
N/A
EBIT
N/A
EBITDA
N/A
Free cash flow
N/A
Per share
EPS
N/A
EPS diluted
N/A
Free cash flow per share
N/A
Book value per share
$0.27
Revenue per share
N/A
TBVPS
$1.32
Balance sheet
Total assets
$14.26M
Total liabilities
$8.9M
Debt
$0
Equity
$5.36M
Working capital
$5.77M
Liquidity
Debt to equity
0
Current ratio
1.68
Quick ratio
1.59
Net debt/EBITDA
N/A
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
N/A
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ACTU stock price

How has the Actuate Therapeutics stock price performed over time
Intraday
-1.79%
1 week
-0.9%
1 month
-18.62%
1 year
N/A
YTD
-3.39%
QTD
-3.39%

Financial performance

How have Actuate Therapeutics's revenue and profit performed over time
Revenue
N/A
Gross profit
N/A
Operating income
N/A
Net income
N/A
Gross margin
N/A
Net margin
N/A

Growth

What is Actuate Therapeutics's growth rate over time

Valuation

What is Actuate Therapeutics stock price valuation
P/E
N/A
P/B
28.03
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Actuate Therapeutics's equity has soared by 105% from the previous quarter

Efficiency

How efficient is Actuate Therapeutics business performance

Dividends

What is ACTU's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ACTU.

Financial health

How did Actuate Therapeutics financials performed over time
Actuate Therapeutics's total assets is 60% higher than its total liabilities
The total liabilities has plunged by 59% from the previous quarter
ACTU's debt is 100% lower than its equity
Actuate Therapeutics's equity has soared by 105% from the previous quarter
ACTU's debt has shrunk by 100% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.